Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-Severe Atopic Dermatitis”

466 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 466 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07502222
What this trial is testing

Evaluate the Efficacy and Safety of AK139 in Patients With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Moderate-to-Severe Atopic Dermatitis
Akeso 168
Large-scale testing (Phase 3)Study completedNCT03363854
What this trial is testing

Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3

Who this might be right for
Atopic Dermatitis
LEO Pharma 380
Large-scale testing (Phase 3)Study completedNCT00809172
What this trial is testing

Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
Hospices Civils de Lyon 100
Testing effectiveness (Phase 2)Study completedNCT07712536
What this trial is testing

Phase IIa Study of Pharmacokinetics, Safety and Efficacy of QY201 Tablets in Adolescent Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Adolescent Participants With Moderate to Severe Atopic Dermatitis (AD)
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT07011706
What this trial is testing

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisAtopicDermatitis+2 more
Aclaris Therapeutics, Inc. 110
Large-scale testing (Phase 3)Not Yet RecruitingNCT06884891
What this trial is testing

A Phase Ⅲ Comparative Study of QL2108 to Dupixent®

Who this might be right for
Atopic Dermatitis
Qilu Pharmaceutical Co., Ltd. 520
Large-scale testing (Phase 3)Study completedNCT03349060
What this trial is testing

Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 387
Testing effectiveness (Phase 2)Ended earlyNCT03809663
What this trial is testing

A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amgen 251
Large-scale testing (Phase 3)Not Yet RecruitingNCT07784816
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetic Profiles of TLL-018 in Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Hangzhou Highlightll Pharmaceutical Co., Ltd 390
Early research (Phase 1)Study completedNCT02888704
What this trial is testing

Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
EHL Bio Co., Ltd. 13
Early research (Phase 1)Study completedNCT03514511
What this trial is testing

Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
LEO Pharma 47
Large-scale testing (Phase 3)Study completedNCT03422822
What this trial is testing

Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 3,166
Not applicableStudy completedNCT05140239
What this trial is testing

Effects of Abrocitinib Treatment on Skin Barrier Function

Who this might be right for
Atopic Dermatitis
Prof. Dr. Stephan Weidinger 20
Large-scale testing (Phase 3)Ended earlyNCT03559270
What this trial is testing

Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 374
Testing effectiveness (Phase 2)Study completedNCT04212169
What this trial is testing

Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AstraZeneca 148
Not applicableStudy completedNCT06983561
What this trial is testing

Description of the Population With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments and Needs Regarding Emollients

Who this might be right for
Atopic Dermatitis
Pierre Fabre Dermo Cosmetique 80
Large-scale testing (Phase 3)Study completedNCT03952559
What this trial is testing

Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 516
Large-scale testing (Phase 3)Study completedNCT02277743
What this trial is testing

Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Regeneron Pharmaceuticals 671
Testing effectiveness (Phase 2)Ended earlyNCT03831191
What this trial is testing

LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 136
Testing effectiveness (Phase 2)Study completedNCT05544591
What this trial is testing

Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 93
Next Page